Scientists now believe that THC found in marijuana may help prevent Alzheimer’s disease. It does this by stopping the production of amyloid plaques.
An active compound in marijuana called tetrahydrocannabinol (THC) has been found to promote the removal of toxic clumps of amyloid beta protein in the brain, which are thought to kickstart the progression of Alzheimer’s disease.
The finding supports the results of previous studies that found evidence of the protective effects of cannabinoids, including THC, on patients with neurodegenerative disease.
“Although other studies have offered evidence that cannabinoids might be neuroprotective against the symptoms of Alzheimer’s, we believe our study is the first to demonstrate that cannabinoids affect both inflammation and amyloid beta accumulation in nerve cells,” says one of the team, David Schubert from the Salk Institute for Biological Studies in California.
Schubert and his colleagues tested the effects of THC on human neurons grown in the lab that mimic the effects of Alzheimer’s disease.
Pharma’s war on marijuana is defined and unrelenting. They’ve donated large sums of money to fight against its legalization. Additionally, they’ve allegedly put out propaganda suggesting that marijuana is a gateway drug. Marijuana advocates claim that the plant is a natural medicinal solution to a great many ailments, including anxiety, which is a major source of income for pharmaceutical ventures with their SSRI line of meds. It is definitely no wonder why pharmaceutical companies might want to suppress any marijuana accolades.